These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line. Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825 [TBL] [Abstract][Full Text] [Related]
3. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells. Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial alterations induced by serum amine oxidase and spermine on human multidrug resistant tumor cells. Arancia G; Calcabrini A; Marra M; Crateri P; Artico M; Martone A; Martelli F; Agostinelli E Amino Acids; 2004 Jun; 26(3):273-82. PubMed ID: 15221508 [TBL] [Abstract][Full Text] [Related]
5. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
6. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells. Munteanu E; Verdier M; Grandjean-Forestier F; Stenger C; Jayat-Vignoles C; Huet S; Robert J; Ratinaud MH Biochem Pharmacol; 2006 Apr; 71(8):1162-74. PubMed ID: 16499877 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo. O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895 [TBL] [Abstract][Full Text] [Related]
9. Biological characterization of multidrug-resistant human colon carcinoma sublines induced/selected by two methods. Yang LY; Trujillo JM Cancer Res; 1990 Jun; 50(11):3218-25. PubMed ID: 2334917 [TBL] [Abstract][Full Text] [Related]
10. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852 [TBL] [Abstract][Full Text] [Related]
11. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells. Limtrakul P; Siwanon S; Yodkeeree S; Duangrat C Phytomedicine; 2007 Jun; 14(6):381-9. PubMed ID: 17467965 [TBL] [Abstract][Full Text] [Related]
12. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution. Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675 [TBL] [Abstract][Full Text] [Related]
13. Circumvention of tumor multidrug resistance by a new annonaceous acetogenin: atemoyacin-B. Fu LW; Pan QC; Liang YJ; Huang HB Zhongguo Yao Li Xue Bao; 1999 May; 20(5):435-9. PubMed ID: 10678092 [TBL] [Abstract][Full Text] [Related]
14. Invasive properties of multidrug resistant human melanoma cells. Molinari A; Stringaro A; Gentile M; Colone M; Toccacieli L; Arancia G Ital J Anat Embryol; 2005; 110(2 Suppl 1):135-41. PubMed ID: 16101031 [TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5. Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135 [TBL] [Abstract][Full Text] [Related]
16. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169 [TBL] [Abstract][Full Text] [Related]
17. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells. Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353 [TBL] [Abstract][Full Text] [Related]
18. Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells. Meschini S; Marra M; Condello M; Calcabrini A; Federici E; Dupuis ML; Cianfriglia M; Arancia G Int J Oncol; 2005 Dec; 27(6):1597-603. PubMed ID: 16273216 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein. Shi Z; Liang YJ; Chen ZS; Wang XH; Ding Y; Chen LM; Fu LW Oncol Rep; 2007 Apr; 17(4):969-76. PubMed ID: 17342344 [TBL] [Abstract][Full Text] [Related]
20. Benzquinamide inhibits P-glycoprotein mediated drug efflux and potentiates anticancer agent cytotoxicity in multidrug resistant cells. Mazzanti R; Croop JM; Gatmaitan Z; Budding M; Steiglitz K; Arceci R; Arias IM Oncol Res; 1992; 4(8-9):359-65. PubMed ID: 1362504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]